Conference item

Phase-3 randomized trial of everolimus (RAD001) vs. placebo in advanced pancreatic NET (RADIANT-3)

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Chambers, J., Reed, N., Mansoor, W., Ross, P., & Grossman, A. (2010). Phase-3 randomized trial of everolimus (RAD001) vs. placebo in advanced pancreatic NET (RADIANT-3). REGULATORY PEPTIDES, 164(1), 6–7.

MLA Style

Chambers, J., et al. “Phase-3 Randomized Trial of Everolimus (RAD001) vs. Placebo in Advanced Pancreatic NET (RADIANT-3).” REGULATORY PEPTIDES, vol. 164, no. 1, 2010, pp. 6–7.

Chicago Style

Chambers, J, N Reed, W Mansoor, P Ross, and A Grossman. 2010. “Phase-3 Randomized Trial of Everolimus (RAD001) vs. Placebo in Advanced Pancreatic NET (RADIANT-3).” In REGULATORY PEPTIDES, 164:6–7.
Share
Print

Access Document

Publisher copy:: 10.1016/j.regpep.2010.07.018

Authors

+ Chambers, J More by this author

Role:: Author

+ Reed, N More by this author

Role:: Author

+ Mansoor, W More by this author

Role:: Author

+ Ross, P More by this author

Role:: Author

+ Grossman, A More by this author

Institution:: University of Oxford
Division:: MSD
Department:: RDM
Sub department:: OCDEM
Role:: Author

Host title:: REGULATORY PEPTIDES
Volume:: 164
Issue:: 1
Pages:: 6-7
Publication date:: 2010-09-09
DOI:: 10.1016/j.regpep.2010.07.018
ISSN:: 0167-0115

Pubs id:: pubs:138714
UUID:: uuid:08a3df25-3222-48ca-b842-cbfebf8c8dd9
Local pid:: pubs:138714
Source identifiers:: 138714
Deposit date:: 2012-12-19

Terms of use

Copyright date:: 2010

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP